These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33641212)

  • 21. Design of a serum stability tag for bioactive peptides.
    Jambunathan K; Galande AK
    Protein Pept Lett; 2014; 21(1):32-8. PubMed ID: 24354769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extension of in vivo half-life of biologically active peptides via chemical conjugation to XTEN protein polymer.
    Podust VN; Sim BC; Kothari D; Henthorn L; Gu C; Wang CW; McLaughlin B; Schellenberger V
    Protein Eng Des Sel; 2013 Nov; 26(11):743-53. PubMed ID: 24133142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of fluorination on proteolytic stability of peptides in human blood plasma.
    Asante V; Mortier J; Schlüter H; Koksch B
    Bioorg Med Chem; 2013 Jun; 21(12):3542-6. PubMed ID: 23623671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A retro-inverso peptide homologous to helix 1 of c-Myc is a potent and specific inhibitor of proliferation in different cellular systems.
    Pescarolo MP; Bagnasco L; Malacarne D; Melchiori A; Valente P; Millo E; Bruno S; Basso S; Parodi S
    FASEB J; 2001 Jan; 15(1):31-33. PubMed ID: 11099487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Degradation and Stabilization of Peptide Hormones in Human Blood Specimens.
    Yi J; Warunek D; Craft D
    PLoS One; 2015; 10(7):e0134427. PubMed ID: 26222180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of fluorination on proteolytic stability of peptides: a case study with α-chymotrypsin and pepsin.
    Asante V; Mortier J; Wolber G; Koksch B
    Amino Acids; 2014 Dec; 46(12):2733-44. PubMed ID: 25193166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design of peptidase-resistant peptide inhibitors of myosin light chain kinase.
    Khapchaev AY; Kazakova OA; Samsonov MV; Sidorova MV; Bushuev VN; Vilitkevich EL; Az'muko AA; Molokoedov AS; Bespalova ZD; Shirinsky VP
    J Pept Sci; 2016 Nov; 22(11-12):673-681. PubMed ID: 27699916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. De novo development of proteolytically resistant therapeutic peptides for oral administration.
    Kong XD; Moriya J; Carle V; Pojer F; Abriata LA; Deyle K; Heinis C
    Nat Biomed Eng; 2020 May; 4(5):560-571. PubMed ID: 32393891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PEPlife: A Repository of the Half-life of Peptides.
    Mathur D; Prakash S; Anand P; Kaur H; Agrawal P; Mehta A; Kumar R; Singh S; Raghava GP
    Sci Rep; 2016 Nov; 6():36617. PubMed ID: 27819351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. α/β-Peptide Foldamers Targeting Intracellular Protein-Protein Interactions with Activity in Living Cells.
    Checco JW; Lee EF; Evangelista M; Sleebs NJ; Rogers K; Pettikiriarachchi A; Kershaw NJ; Eddinger GA; Belair DG; Wilson JL; Eller CH; Raines RT; Murphy WL; Smith BJ; Gellman SH; Fairlie WD
    J Am Chem Soc; 2015 Sep; 137(35):11365-75. PubMed ID: 26317395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization of Protein and Peptide Drugs Based on the Mechanisms of Kidney Clearance.
    Wu H; Huang J
    Protein Pept Lett; 2018; 25(6):514-521. PubMed ID: 29848260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In silico approaches for predicting the half-life of natural and modified peptides in blood.
    Mathur D; Singh S; Mehta A; Agrawal P; Raghava GPS
    PLoS One; 2018; 13(6):e0196829. PubMed ID: 29856745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of 2-component i, i + 3 peptide stapling using thioethers.
    St Louis LE; Rodriguez TM; Waters ML
    Bioorg Med Chem; 2018 Mar; 26(6):1203-1205. PubMed ID: 29122441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The design, synthesis and application of stereochemical and directional peptide isomers: a critical review.
    Fischer PM
    Curr Protein Pept Sci; 2003 Oct; 4(5):339-56. PubMed ID: 14529528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methods to Enhance the Metabolic Stability of Peptide-Based PET Radiopharmaceuticals.
    Evans BJ; King AT; Katsifis A; Matesic L; Jamie JF
    Molecules; 2020 May; 25(10):. PubMed ID: 32423178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability.
    Yao JF; Yang H; Zhao YZ; Xue M
    Curr Drug Metab; 2018; 19(11):892-901. PubMed ID: 29956618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategic approaches to optimizing peptide ADME properties.
    Di L
    AAPS J; 2015 Jan; 17(1):134-43. PubMed ID: 25366889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptide Backbone Composition and Protease Susceptibility: Impact of Modification Type, Position, and Tandem Substitution.
    Werner HM; Cabalteja CC; Horne WS
    Chembiochem; 2016 Apr; 17(8):712-8. PubMed ID: 26205791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular basis of branched peptides resistance to enzyme proteolysis.
    Falciani C; Lozzi L; Pini A; Corti F; Fabbrini M; Bernini A; Lelli B; Niccolai N; Bracci L
    Chem Biol Drug Des; 2007 Mar; 69(3):216-21. PubMed ID: 17441908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.